NCT06489366

Brief Summary

The efficacy of Ho: YAG and TFL combined with semirigid ureteroscopic treatment of proximal ureteral stones will be compared.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
138

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 26, 2024

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

June 28, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 5, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 26, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 26, 2025

Completed
Last Updated

July 5, 2024

Status Verified

June 1, 2024

Enrollment Period

7 months

First QC Date

June 28, 2024

Last Update Submit

June 28, 2024

Conditions

Keywords

Proximal ureteral stonesHo: YAG lithotripsyThulium Fiber laser (TFL) lithotripsySemirigid ureteroscopic lithotripsy

Outcome Measures

Primary Outcomes (1)

  • Stone-free rate (SFR)

    Stone-free rate (SFR) after single-session laser lithotripsy using a semirigid ureteroscope without an auxiliary procedure assessed by CT/X-ray at 2-4 weeks follow-up after laser lithotripsy.

    2-4 weeks after surgery

Secondary Outcomes (4)

  • Operative time

    Immediately during surgery

  • Intraoperative complications

    Immediately during surgery

  • Postoperative complications

    2-4 weeks after surgery

  • Additional procedures

    Intraoperatively and before removal of the Ureteral stents

Study Arms (2)

Ho: YAG lithotripsy

ACTIVE COMPARATOR

Ho; YAG laser therapy device is used. The patient adopts lithotomy position. After general anesthesia, a semi-rigid ureteroscope is used to enter the bladder through the urethra to observe the ureteral opening, and then a hydrophilic guide wire is inserted into the ureter on the affected side. After the semi-rigid ureteroscope slowly enters along the hydrophilic guide wire and reaches the bottom of the stone, the laser optical fiber of the laser therapy device is inserted into the working channel of the ureteroscope so that the end of the optical fiber is exposed in the field of view of the ureteroscope. After the laser therapy device sets the lithotripsy parameters, the optical fiber is aimed at the stone for laser lithotripsy.

Device: Ho: YAG lithotripsy

Thulium Fiber laser (TFL) lithotripsy

EXPERIMENTAL

The patient adopts lithotomy position. After general anesthesia, a semi-rigid ureteroscope is used to enter the bladder through the urethra to observe the ureteral opening, and then a hydrophilic guide wire is inserted into the ureter on the affected side. After the semi-rigid ureteroscope slowly enters along the hydrophilic guide wire and reaches the bottom of the stone, the laser fiber of the laser therapy machine is inserted into the working channel of the ureteroscope so that the end of the fiber is exposed to the field of view of the ureteroscope. Using the TFL laser therapy device, after setting the lithotripsy parameters, the fiber is aimed at the stone for laser lithotripsy.

Device: Thulium Fiber laser (TFL) lithotripsy

Interventions

Patients with proximal ureteral stones undergoing ureteroscopic lithotripsy using thulium laser lithotripsy.

Thulium Fiber laser (TFL) lithotripsy

Ho:YAG laser lithotripsy was used in patients with proximal ureteral stones undergoing ureteroscopic lithotripsy.

Ho: YAG lithotripsy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ≥18 years old;
  • patients diagnosed with unilateral proximal ureteral stones ≤2cm by computed tomography (CT)/Kidney and upper bladder (KUB) radiography who required surgery;
  • patients who volunteered to participate in this study.

You may not qualify if:

  • Unable to give informed consent;
  • Untreated urinary tract infection;
  • Pregnant women;
  • Known anatomical abnormalities (such as urinary diversion or ureteral stenosis);
  • Urothelial tumors, transplanted kidney stones, irreversible coagulopathy;
  • The semi-rigid ureteroscope cannot reach the stone site, ureteroscopy-negative stones, and stones can be removed directly without laser lithotripsy;
  • The researchers believe that they are not suitable for participation in this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhongnan Hospital, Wuhan University,

Wuhan, Hubei, 430071, China

Location

MeSH Terms

Conditions

Urolithiasis

Interventions

Lithotripsy

Condition Hierarchy (Ancestors)

Urologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

TherapeuticsUltrasonic Surgical ProceduresSurgical Procedures, Operative

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Patients and data analysts were blinded to the allocation measures.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 28, 2024

First Posted

July 5, 2024

Study Start

June 26, 2024

Primary Completion

January 26, 2025

Study Completion

February 26, 2025

Last Updated

July 5, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations